Randomized, double‐blind, placebo‐controlled study of interferon‐γ 1b in Friedreich Ataxia
Open Access
- 27 February 2019
- journal article
- research article
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 6 (3) , 546-553
Abstract
Objective: In vitro, in vivo, and open‐label studies suggest that interferon gamma (IFN‐γ 1b) may improve clinical features in Friedreich Ataxia through an increase in frataxin levels. The present study evaluates the efficacy and safety of IFN‐γ 1b in the treatment of Friedreich Ataxia through a double‐blind, multicenter, placebo‐controlled trial.Methods: Ninety‐two subjects with FRDA between 10 and 25 years of age were enrolled. Subjects received either IFN‐γ 1b or placebo for 6 months. The primary outcome measure was the modified Friedreich Ataxia Rating Scale (mFARS).Results: No difference was noted between the groups after 6 months of treatment in the mFARS or secondary outcome measures. No change was noted in buccal cell or whole blood frataxin levels. However, during an open‐label extension period, subjects had a more stable course than expected based on natural history data.Conclusions: This study provides no direct evidence for a beneficial effect of IFN‐γ1b in FRDA. The modest stabilization compared to natural history data leaves open the possibility that longer studies may demonstrate benefit.Keywords
Funding Information
- Horizon Pharma
- University of California, Los Angeles
- University of Iowa
- University of Florida
- University of Rochester
This publication has 25 references indexed in Scilit:
- Pharmacological therapeutics in Friedreich ataxia: the present stateExpert Review of Neurotherapeutics, 2017
- Open-label pilot study of interferon gamma-1b in Friedreich ataxiaActa Neurologica Scandinavica, 2014
- Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulationFrontiers in Pharmacology, 2014
- Usefulness of frataxin immunoassays for the diagnosis of Friedreich ataxiaJournal of Neurology, Neurosurgery & Psychiatry, 2014
- Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia modelHuman Molecular Genetics, 2012
- The cerebellar component of Friedreich’s ataxiaActa Neuropathologica, 2011
- The Neuropathology of Late-Onset Friedreich’s AtaxiaThe Cerebellum, 2010
- A rapid, noninvasive immunoassay for frataxin: Utility in assessment of Friedreich ataxiaMolecular Genetics and Metabolism, 2010
- Friedreich ataxia: The clinical pictureJournal of Neurology, 2009
- Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat ExpansionScience, 1996